Douglas Reed M.D., Director at TETRALOGIC PHARMACEUTICALS CORP (TLOG), bought 1,209,742 shares at $7.00 ($3.0M) on 2013-12-17, disclosed to the SEC on 2013-12-19.
Open-market purchase of $3.0M TLOG by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 780,980 | $0 | 0.0% |
| 2 | $6.40 | 7,590 | $49K | 1.6% |
| 3 | $7.00 | 142,857 | $1000K | 33.4% |
| 4 | $7.00 | 278,315 | $1.9M | 65.0% |
| Total | $2.48 avg | 1,209,742 | $3.0M | 100% |
| Filing → |
| GTHX | BUY | 2017-05-24 | $2.0M | — | Filing → |
| CLSD | SELL | 2017-01-19 | $512K | — | Filing → |
| DRAD | SELL | 2007-08-27 | $92K | — | Filing → |